SCHEMBL20248908

SCHEMBL20248908

O=C(c1ccc(-c2cc3c(-c4ccccc4)c4sccc4c(-c4ccccc4)c3s2)cc1)c1ccc(-c2cc3c(-c4ccccc4)c4sccc4c(-c4ccccc4)c3s2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 1/20 0.43
▸ SCD O00767 2/20 0.41
▸ ATM Q13315 2/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ PTP4A3 O75365 1/20 0.37
▸ PTP4A2 Q12974 1/20 0.37
▸ PTP4A1 Q93096 1/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ MAPT P10636 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ JAK2 O60674 1/20 0.37
▸ JAK1 P23458 1/20 0.37
▸ TYK2 P29597 1/20 0.37
▸ JAK3 P52333 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20248903 0.99 ADORA1 (0.45) ADORA1SCDATMTDP1L3MBTL1
SCHEMBL20248872 0.85 ADORA2A (0.46) ADORA1L3MBTL1PTP4A3PTP4A2PTP4A1
SCHEMBL20248873 0.84 ADORA2A (0.45) ADORA1PTP4A3PTP4A2PTP4A1MEN1
SCHEMBL20248879 0.83 PTP4A3 (0.39) L3MBTL1PTP4A3PTP4A2PTP4A1POLB
SCHEMBL20248901 0.82 MEN1 (0.43) ADORA1TDP1MEN1KMT2AMAPT
SCHEMBL20248876 0.82 PTP4A3 (0.39) L3MBTL1PTP4A3PTP4A2PTP4A1ALDH1A1
SCHEMBL20248869 0.81 ADORA2A (0.42) ADORA1PTP4A3PTP4A2PTP4A1MEN1
SCHEMBL20248868 0.80 ADORA2A (0.44) ADORA1PTP4A3PTP4A2PTP4A1MAPT
SCHEMBL20248904 0.79 NPC1 (0.44) MEN1KMT2AMAPTRAB9AALDH1A1
SCHEMBL14902909 0.79 PLK4 (0.43) MEN1KMT2ARAB9AALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10347846-B2 Organic compound for organic EL device and using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2019-07-09 — — US disclosed
US-20180166640-A1 ORGANIC COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2018-06-14 — — US disclosed
US-20180166640-A1 ORGANIC COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2018-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10347846-B2 Organic compound for organic EL device and using the same L1CAM, ESR1, XPO4 ADORA1 912/4885SCD 3900/4885ATM 3446/4885
US-20180166640-A1 ORGANIC COMPOUND FOR ORGANIC EL DEVICE AND USING THE SAME L1CAM, ESR1, XPO4 ADORA1 912/4885SCD 3900/4885ATM 3446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback